Suppr超能文献

穿透性角膜移植术的十二年随访

Twelve-year follow-up of penetrating keratoplasty.

作者信息

Ono Takashi, Ishiyama Sosuke, Hayashidera Takeshi, Mori Yosai, Nejima Ryohei, Miyata Kazunori, Amano Shiro

机构信息

Miyata Eye Hospital, Miyakonojo, Japan.

Inouye Eye Hospital, 4-3 Kandasurugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.

出版信息

Jpn J Ophthalmol. 2017 Mar;61(2):131-136. doi: 10.1007/s10384-016-0489-2. Epub 2016 Nov 24.

Abstract

PURPOSE

To evaluate the long-term outcomes of penetrating keratoplasty (PKP) according to the corneal disease diagnosis and the number of PKP procedures performed.

METHODS

Five-hundred-and-nine eyes from 403 patients who underwent PKP at Miyata Eye Hospital in Japan from 1998 through 2014, were included in this study. Medical charts were retrospectively examined to ascertain the corneal disease diagnosis and the period of graft survival. Graft survival rates were compared among various corneal disease diagnoses and among the number of PKP procedures performed. Changes in corneal endothelial cell density (ECD) were analyzed using a mixed-effects model. The presence/absence of various risk factors was compared between transparent grafts and failed grafts.

RESULTS

The overall rate of graft survival at 12 years was 60.4%. The rates of graft survival in keratoconus was 100%, in corneal dystrophy 100%, in leukoma 70.8%, and in bullous keratopathy 51.7%. The rates of graft survival at 12 years for the first PKP was 65.4% and for the second PKP, 43.4% (p < 0.001). All cases of third PKP and fourth PKP failed within 8 years. Preoperative mean ECD (95% confidence interval) was 2722 (2666-2778) cells/mm; it decreased exponentially after PKP. Mean ECD was 659 (440-878) cells/mm at 10 years. Rejection, trauma, and infection occurred significantly more frequently in failed grafts than in transparent grafts.

CONCLUSIONS

The long-term prognosis of PKP depends on the original diagnosis. The long-term prognosis of re-grafting is worse than that of primary grafts. Rejection, trauma, and infection are risk factors for graft failure.

摘要

目的

根据角膜疾病诊断和穿透性角膜移植术(PKP)的手术次数评估PKP的长期疗效。

方法

本研究纳入了1998年至2014年在日本宫田眼科医院接受PKP的403例患者的509只眼睛。回顾性查阅病历以确定角膜疾病诊断和移植存活期。比较了不同角膜疾病诊断以及不同PKP手术次数之间的移植存活率。使用混合效应模型分析角膜内皮细胞密度(ECD)的变化。比较了透明移植和失败移植之间各种危险因素的有无。

结果

12年时的总体移植存活率为60.4%。圆锥角膜的移植存活率为100%,角膜营养不良为100%,角膜白斑为70.8%,大疱性角膜病变为51.7%。首次PKP 12年时的移植存活率为65.4%,第二次PKP为43.4%(p<0.001)。所有第三次和第四次PKP病例均在8年内失败。术前平均ECD(95%置信区间)为2722(2666 - 2778)个细胞/mm²;PKP后呈指数下降。10年时平均ECD为659(440 - 878)个细胞/mm²。失败移植中排斥、创伤和感染的发生率明显高于透明移植。

结论

PKP的长期预后取决于最初的诊断。再次移植的长期预后比初次移植差。排斥、创伤和感染是移植失败的危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验